Diagnosis and treatment of tuberculosis complicated with diabetes

doi:10.19983/j.issn.2096-8493.20210111

Abstract

Abstract:

Tuberculosis is one of the most important public health problems in the world. Diabetes is the third major chronic non-communicable disease threating human health. Tuberculosis patients with diabetes are more likely to meet treatment failure and have a higher risk of death. In this paper, the mutual harm, diagnosis, treatment and management of tuberculosis and diabetes comorbidity are discussed in order to raise the attention of clinical health care workers and provoke further research.

Key words: Tuberculosis, Diabetes, Combined, Practice management, medical, Drug therapy, combination, Drug interactions

CLC Number:

R521
R587.1

TIAN Yao, LIU Hui-min, FU Man-jiao, BEI Cheng-li. Diagnosis and treatment of tuberculosis complicated with diabetes[J]. Journal of Tuberculosis and Lung Disease , 2022, 3(2): 91-95. doi: 10.19983/j.issn.2096-8493.20210111

References 39

[1]	World Health Organization. Global tuberculosis report 2021. Geneva:World Health Organization, 2021.
[2]	Misra A, Gopalan H, Jayawardena R, et al. Diabetes in developing countries. J Diabetes, 2019, 11(7):522-539. doi: 10.1111/1753-0407.12913. doi: 10.1111/1753-0407.12913 URL
[3]	Al-Rifai RH, Pearson F, Critchley JA, et al. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One, 2017, 12(11):e0187967. doi: 10.1371/journal.pone.0187967. doi: 10.1371/journal.pone.0187967 URL
[4]	Cadena J, Rathinavelu S, Lopez-Alvarenga JC, et al. The re-emerging association between tuberculosis and diabetes: Lessons from past centuries. Tuberculosis (Edinb), 2019, 116S:S89-S97. doi: 10.1016/j.tube.2019.04.015. doi: 10.1016/j.tube.2019.04.015
[5]	Ayelign B, Negash M, Genetu M, et al. Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis. J Immunol Res, 2019, 2019:6196532. doi: 10.1155/2019/6196532. doi: 10.1155/2019/6196532
[6]	吴桂辉, 唐先珍, 黄涛, 等. 复治涂阳肺结核并发糖尿病患者临床特点及耐药性相关分析. 中国防痨杂志, 2021, 43(10):1016-1021. doi: 10.3969/j.issn.1000-6621.2021.10.008. doi: 10.3969/j.issn.1000-6621.2021.10.008
[7]	Armstrong LR, Kammerer JS, Haddad MB. Diabetes mellitus among adults with tuberculosis in the USA, 2010-2017. BMJ Open Diabetes Res Care, 2020, 8(1):e001275. doi: 10.1136/bmjdrc-2020-001275. doi: 10.1136/bmjdrc-2020-001275 URL
[8]	曾剑锋, 杨敏, 唐芳, 等. 糖尿病住院患者并发肺结核的临床特征分析. 中国防痨杂志, 2021, 43(1):31-35. doi: 10.3969/j.issn.1000-6621.2021.01.007. doi: 10.3969/j.issn.1000-6621.2021.01.007
[9]	Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012, 17(10):1302-1308. doi: 10.1111/j.1365-3156.2012.03069.x. doi: 10.1111/j.1365-3156.2012.03069.x URL
[10]	Ji Y, Cao H, Liu Q, et al. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis, 2020, 93:84-89. doi: 10.1016/j.ijid.2020.01.019. doi: 10.1016/j.ijid.2020.01.019 URL
[11]	汪娟, 许缃, 蔡晓峰, 等. 对糖尿病患者进行肺结核筛查的效果与成本效益分析. 中国防痨杂志, 2019, 41(9):968-973. doi: 10.3969/j.issn.1000-6621.2019.09.011. doi: 10.3969/j.issn.1000-6621.2019.09.011
[12]	Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Glob Health, 2019, 7(4):e448-e460. doi: 10.1016/S2214-109X(18)30487-X. doi: 10.1016/S2214-109X(18)30487-X URL
[13]	Grint D, Alisjhabana B, Ugarte-Gil C, et al. Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa. Bull World Health Organ, 2018, 96(11):738-749. doi: 10.2471/BLT.17.206227. doi: 10.2471/BLT.17.206227 URL
[14]	Cheng J, Zhang H, Zhao YL, et al. Mutual Impact of Diabetes Mellitus and Tuberculosis in China. Biomed Environ Sci, 2017, 30(5):384-389. doi: 10.3967/bes2017.051. doi: 10.3967/bes2017.051 pmid: 28549496
[15]	中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09.
[16]	Boehme CC, Saacks S, O’Brien RJ. The changing landscape of diagnostic services for tuberculosis. Semin Respir Crit Care Med, 2013, 34(1):17-31. doi: 10.1055/s-0032-1333468. doi: 10.1055/s-0032-1333468 URL
[17]	焦伟伟. 儿童结核病分子生物学诊断方法研究进展. 结核与肺部疾病杂志, 2021, 2(1):69-72. doi: 10.3969/j.issn.2096-8493.2021.01.015. doi: 10.3969/j.issn.2096-8493.2021.01.015
[18]	卢水华, 陆伟. 重组结核杆菌融合蛋白(EC)临床应用专家共识. 中国防痨杂志, 2020, 42(8):761-768. doi: 10.3969/i.issn.1000-6621.2020.08.001. doi: 10.3969/i.issn.1000-6621.2020.08.001
[19]	中华人民共和国国家质量监督检验检疫总局, 中国国家标准化管理委员会. WS 397—2012糖尿病筛查和诊断. 北京: 中国标准出版社, 2012.
[20]	韩娜. 糖尿病合并肺结核临床特点及诊治分析. 临床肺科杂志, 2014, 19(3):558-560. doi: 10.3969/j.issn.1672-5131.2021.07.017. doi: 10.3969/j.issn.1672-5131.2021.07.017
[21]	赵丽, 范克, 李威, 等. 结核病合并糖尿病患者CT影像学特征及诊断价值. 中国CT和MRI杂志, 2021, 19(7):55-56,96. doi: 10.3969/j.issn.1672-5131.2021.07.017. doi: 10.3969/j.issn.1672-5131.2021.07.017
[22]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1):12-22. doi: 10.3969/j.issn.1000-6621.2021.01.004. doi: 10.3969/j.issn.1000-6621.2021.01.004
[23]	World Health Organization. Guidelines for treatment of drugsusceptible tuberculosis and patient care, 2017 update. Geneva:World Health Organization, 2017.
[24]	World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2019.
[25]	van Crevel R, Koesoemadinata R, Hill PC, et al. Clinical management of combined tuberculosis and diabetes. Int J Tuberc Lung Dis, 2018, 22(12):1404-1410. doi: 10.5588/ijtld.18.0340. doi: 10.5588/ijtld.18.0340 pmid: 30606312
[26]	李百远, 李元军, 高非凡. 二甲双胍辅助抗结核的作用机制及临床价值. 临床荟萃, 2021, 36(2):179-183. doi: 10.3969/j.issn.1004-583X.2021.02.017. doi: 10.3969/j.issn.1004-583X.2021.02.017
[27]	韩喜琴. 二甲双胍作为宿主导向治疗对结核病合并糖尿病的作用. 中国临床医生杂志, 2020, 48(12):1394-1396. doi: 10.3969/j.issn.2095-8552.2020.12.003. doi: 10.3969/j.issn.2095-8552.2020.12.003
[28]	Mtabho CM, Semvua HH, van den Boogaard J, et al. Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients. J Antimicrob Chemother, 2019, 74(12):3537-3545. doi: 10.1093/jac/dkz368. doi: 10.1093/jac/dkz368 URL
[29]	中华医学会结核病学分会重症专业委员会. 结核病营养治疗专家共识. 中华结核和呼吸杂志, 2020, 43(1):17-26. doi: 10.3760/cma.j.issn.1001-0939.2020.01.006. doi: 10.3760/cma.j.issn.1001-0939.2020.01.006
[30]	张胜康, 童照威, 唐寒梅, 等. 必须重视结核病患者的营养治疗. 中国防痨杂志, 2020, 42(12):1272-1275. doi: 10.3969/j.issn.1000-6621.2020.12.004. doi: 10.3969/j.issn.1000-6621.2020.12.004
[31]	曾金燕. 肺结核患者治疗依从性的影响因素和对策研究. 临床医学工程, 2018, 25(3):397-398. doi: 10.3969/j.issn.1674-4659.2018.03.0397. doi: 10.3969/j.issn.1674-4659.2018.03.0397
[32]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 肺结核基层诊疗指南(2018年). 中华全科医师杂志, 2019, 18(8):709-717. doi: 10.3760/cma.j.issn.1671-7368.2019.08.002. doi: 10.3760/cma.j.issn.1671-7368.2019.08.002
[33]	李亚敏, 高志东, 陈曦, 等. 移动互联网技术用于社区肺结核患者健康管理的接受意愿调查分析. 中国防痨杂志, 2020, 42(12):1313-1317. doi: 10.3969/j.issn.1000-6621.2020.12.012. doi: 10.3969/j.issn.1000-6621.2020.12.012
[34]	李源, 高风华, 金锋. DOTS联合微信管理方式对肺结核患者治疗管理效果的评价. 结核与肺部疾病杂志, 2021, 2(1):50-53. doi: 10.3969/j.issn.2096-8493.2021.01.011. doi: 10.3969/j.issn.2096-8493.2021.01.011
[35]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版). 中华糖尿病杂志, 2021, 13(4):315-409. doi: 10.3760/cma.j.cn115791-20210221-00095. doi: 10.3760/cma.j.cn115791-20210221-00095
[36]	王俊薇, 刘云, 李连喜. 中国糖尿病管理模式及思考. 中国全科医学, 2021, 24(24):3019-3025. doi: 10.12114/j.issn.1007-9572.2021.00.551. doi: 10.12114/j.issn.1007-9572.2021.00.551
[37]	邓国防, 成诗明. 浅谈我国结核病与糖尿病共病治疗管理现状. 中国防痨杂志, 2021, 43(1):23-25. doi: 10.3969/j.issn.1000-6621.2021.01.005. doi: 10.3969/j.issn.1000-6621.2021.01.005
[38]	中华人民共和国卫生与计划生育委员会. 肺结核患者健康管理服务规范.国卫办基层函(2015)880号. 2015-10-27.
[39]	周倩. 多学科团队管理对肺结核合并糖尿病病人生活质量的影响. 护理研究, 2013, 27(33):3815-3816. doi: 10.3969/j.issn.1009-6493.2013.33.056. doi: 10.3969/j.issn.1009-6493.2013.33.056